Drug Shortage Report for ESTALIS 250/50 MCG
Report ID | 123862 |
Drug Identification Number | 02241837 |
Brand name | ESTALIS 250/50 MCG |
Common or Proper name | ESTALIS 250/50 MCG 8'S |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ESTRADIOL NORETHINDRONE ACETATE |
Strength(s) | 50MCG 250MCG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 8's |
ATC code | G03FA |
ATC description | PROGESTOGENS AND ESTROGENS IN COMBINATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-09-04 |
Actual start date | 2020-09-02 |
Estimated end date | 2020-09-24 |
Actual end date | 2020-09-22 |
Shortage status | Resolved |
Updated date | 2020-09-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-09-23 | French | Compare |
v8 | 2020-09-23 | English | Compare |
v7 | 2020-09-22 | French | Compare |
v6 | 2020-09-22 | English | Compare |
v5 | 2020-09-22 | English | Compare |
v4 | 2020-09-22 | French | Compare |
v3 | 2020-09-22 | English | Compare |
v2 | 2020-09-08 | French | Compare |
v1 | 2020-09-08 | English | Compare |
Showing 1 to 9 of 9